Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSSAR441255 is a peptide triple agonist of the glucagon-like peptide 1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR).1 It induces cAMP accumulation in HEK293 cells expressing human GLP-1R, GIPR, or GCGR (EC50s = 1.03, 0.73, and 1.01 pM, respectively). SAR441255 (1-30 µg/kg) reduces body weight in a mouse model of high-fat diet-induced obesity. It also reduces body weight and blood hemoglobin A1c (HbA1c) levels in high-fat diet-induced obese diabetic cynomolgus monkeys when administered at a dose of 11 µg/kg.
WARNING This product is not for human or veterinary use.
1. Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-